Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Dec;66(6):984-92.
doi: 10.1053/j.ajkd.2015.06.015. Epub 2015 Jul 21.

Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study

Kyle E Rodenbach  1 , Michael F Schneider  2 , Susan L Furth  3 , Marva M Moxey-Mims  4 , Mark M Mitsnefes  5 , Donald J Weaver  6 , Bradley A Warady  7 , George J Schwartz  8
Affiliations
Observational Study

Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study

Kyle E Rodenbach et al. Am J Kidney Dis. 2015 Dec.

Abstract

Background: Hyperuricemia is associated with essential hypertension in children. No previous studies have evaluated the effect of hyperuricemia on progression of chronic kidney disease (CKD) in children.

Study design: Prospective observational cohort study.

Setting & participants: Children and adolescents (n=678 cross-sectional; n=627 longitudinal) with a median age of 12.3 (IQR, 8.6-15.6) years enrolled at 52 North American sites of the CKiD (CKD in Children) Study.

Predictor: Serum uric acid level (<5.5, 5.5-7.5, and >7.5mg/dL).

Outcomes: Composite end point of either >30% decline in glomerular filtration rate (GFR) or initiation of renal replacement therapy.

Measurements: Age, sex, race, blood pressure status, GFR, CKD cause, urine protein-creatinine ratio (<0.5, 0.5-<2.0, and ≥2.0mg/mg), age- and sex-specific body mass index > 95th percentile, use of diuretics, and serum uric acid level.

Results: Older age, male sex, lower GFR, and body mass index > 95th percentile were associated with higher uric acid levels. 162, 294, and 171 participants had initial uric acid levels < 5.5, 5.5 to 7.5, or >7.5 mg/dL, respectively. We observed 225 instances of the composite end point over 5 years. In a multivariable parametric time-to-event analysis, compared with participants with initial uric acid levels < 5.5mg/dL, those with uric acid levels of 5.5 to 7.5 or >7.5mg/dL had 17% shorter (relative time, 0.83; 95% CI, 0.62-1.11) or 38% shorter (relative time, 0.62; 95% CI, 0.45-0.85) times to event, respectively. Hypertension, lower GFR, glomerular CKD cause, and elevated urine protein-creatinine ratio were also associated with faster times to the composite end point.

Limitations: The study lacked sufficient data to examine how use of specific medications might influence serum uric acid levels and CKD progression.

Conclusions: Hyperuricemia is a previously undescribed independent risk factor for faster progression of CKD in children and adolescents. It is possible that treatment of children and adolescents with CKD with urate-lowering therapy could slow disease progression.

Keywords: CKD progression; CKiD (Chronic Kidney Disease in Children); Uric acid; adolescents; children; chronic kidney disease (CKD); disease trajectory; end-stage renal disease (ESRD); glomerular filtration rate (GFR); hyperuricemia; pediatric kidney disease; renal function decline; renal replacement therapy (RRT); risk factor; urate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram depicting the distribution of serum Uric Acid at the index visit; median=6.5 (interquartile range, 5.4–7.6) mg/dL (N=678)
Figure 2
Figure 2
Kaplan-Meier and conventional generalized gamma survival curves for the composite end-point of >30% decline in GFR or initiation of RRT.
See this image and copyright information in PMC

References

    1. Feig DI. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 2014;26(2):76–185. - PubMed
    1. Dawson J, Jeemon P, Hetherington L, et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension. 2013;62(1):105–111. - PubMed
    1. Krishnan E, Akhras KS, Sharma H, et al. Serum Urate and Incidence of Kidney Disease Among Veterans with Gout. J Rheumatol. 2013;40(7):1166–1172. - PubMed
    1. Ohta Y, Tsuchihashi T, Kiyohara K, Oniki H. Increased uric acid promotes decline of the renal function in hypertensive patients: a 10-year observational study. Intern Med. 2012;52(13):467–1472. - PubMed
    1. Alper AB, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood Uric Acid Predicts Adult Blood Pressure The Bogalusa Heart Study. Hypertension. 2005;45(1):34–38. - PubMed

Publication types